Akers Logo Top Akers Biosciences  
Akers Logo Bottom
 
 
 
home > technologies
Technologies

ABI knows that low-cost, unit-use testing not only saves time and money, but allows for more frequent, near-patient testing which may save lives. We have broken new ground with FDA-cleared rapid diagnostic tests that help facilitate targeted diagnoses and real-time treatment.

ABI's rapid diagnostic tests surpass most other current diagnostic products with their flexibility, speed, ease-of-use, readability, low cost and accuracy. In minutes, detection of disease states and medical conditions can be performed on single-patient specimens, without sacrificing accuracy. A sample of our technology platforms is provided below:


Particle ImmunoFiltration Assay (PIFA®)

Synthetic Macrocycle Complex (SMC)

Rapid Enzymatic Assay (REA)

Micro Particle Catalyzed (MPC) Biosensor

Biosniffer Continuous Monitoring Detector

minDNA

Our technologies provide uniform platforms for the development of diagnostic tests for many other applications which include numerous metabolites, environmentally sensitive compounds, food-related contaminants and biowarfare agents.

Akers Biosciences Technologies

 

 

 

 

   

© 2008 Akers Biosciences, Inc. All Rights Reserved.
Technical Services